Actively Recruiting
Acupuncture Treatment for Mild to Moderate Active Crohns Disease and Its Effects on Brain and Metabolism
Led by Shanghai Institute of Acupuncture, Moxibustion and Meridian · Updated on 2025-05-14
60
Participants Needed
2
Research Sites
N/A
Total Duration
On this page
Sponsors
S
Shanghai Institute of Acupuncture, Moxibustion and Meridian
Lead Sponsor
F
Fudan University
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are studying the effects of acupuncture on people with mild to moderate active Crohns disease. The study aims to see how acupuncture affects symptoms, brain activity, and the metabolism of certain substances TRY-KYN related to the brain-gut connection. They also want to identify brain imaging markers linked to acupuncture treatment in Crohns disease. The study is led by the Shanghai Institute of Acupuncture, Moxibustion and Meridian. Participants will receive acupuncture and mild moxibustion treatments three times a week for 12 weeks. Specific points on the body such as CV12, ST37, SP6, and others will be used for acupuncture and moxibustion, with a device applied to ensure the sensation of treatment and maintain the temperature of moxibustion points. After the 12-week treatment phase, participants will be followed for an additional 36 weeks to monitor the effects. During the study, participants will be evaluated at various times up to 48 weeks. Researchers will measure clinical remission, symptom improvements, disease activity scores, laboratory tests, quality of life questionnaires, anxiety and depression scales, and endoscopic severity. Brain imaging and metabolism levels of TRP-KYN in plasma and intestines will also be assessed. Safety and recurrence rates will be monitored throughout the study.
CONDITIONS
Brief Title
Effect of Acupuncture on Mild to Moderate Active Crohn's Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aged 16 to 70 years
- Mild or moderate active Crohn's disease (CDAI between 150 and less than 450)
- Not responsive, intolerant, dependent on, or refused to use certain medications including mesalazine, glucocorticoids, immunomodulators, or anti-TNF alpha preparations
- Either not taking medication or taking only prednisone (up to 15 mg/day), azathioprine (up to 1 mg/kg/day), methotrexate (up to 15 mg/week), or mesalazine (up to 4 g/day) with specified minimum treatment durations
- No use of anti-TNF alpha or other agents within 3 months before study entry
- Never had acupuncture before
- Signed informed consent
You will not qualify if you...
- Currently pregnant, recently pregnant, or breastfeeding
- Having serious organic diseases
- Diagnosed with psychosis
- Taking antibiotics, probiotics, traditional Chinese medicine, or other drugs that may affect study results
- Having severe skin diseases, eye diseases, thromboembolic diseases, or serious extraintestinal Crohn's manifestations
- Having serious intestinal complications such as fistula, abscess, stenosis, obstruction, hemorrhage, or perforation
- History of abdominal or gastrointestinal surgery within the past 6 months
- Skin diseases or defects at acupuncture or moxibustion sites preventing treatment
Research Team
C
Chunhui Bao, MD, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here